These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 8960271)

  • 1. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-cubylmethyl substituted morphinoids as novel narcotic antagonists.
    Cheng CY; Hsin LW; Lin YP; Tao PL; Jong TT
    Bioorg Med Chem; 1996 Jan; 4(1):73-80. PubMed ID: 8689242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
    Hruby VJ; Agnes RS
    Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opioid receptors in the era of molecular biology: they account for more than 6,000 years of empirical pharmacology].
    Huidobro-Toro JP
    Rev Med Chil; 1995 May; 123(5):628-36. PubMed ID: 8525211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
    Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
    Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway.
    Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Ostad SN
    Neuroscience; 2007 Feb; 144(3):1075-86. PubMed ID: 17169497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
    Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
    Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of endothelial angiotensin-converting enzyme by morphine via non-opioid receptor mediated processes.
    Melzig MF; Heder G; Siems WE; Zipper J
    Pharmazie; 1998 Sep; 53(9):634-7. PubMed ID: 9770211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.
    King CD; Rios GR; Green MD; MacKenzie PI; Tephly TR
    Drug Metab Dispos; 1997 Feb; 25(2):251-5. PubMed ID: 9029056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of peptides and morphine-like narcotic analgesics with specifically labelled mu- and delta-opiate receptor binding sites.
    Hermans B; Gommeren W; De Potter WP; Leysen JE
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):317-9. PubMed ID: 6136260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Opioid receptors and their selective ligands].
    Piestrzeniewicz MK; Fichna J; Janecka A
    Postepy Biochem; 2006; 52(3):313-9. PubMed ID: 17201067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.